US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1107.08 +5.00 (0.45%)
Previous Close $1102.08    52 Week High $88.16 
Open $1117.00    52 Week Low $67.88 
Day High $1122.02    P/E 256.27 
Day Low $1079.22    EPS $4.32 
Volume 3,312,890